DanielJRaderMD

Grant Support

• Discovery And Validation Of Novel Loci Associated With HDL FunctionNational Heart, Lung, And Blood Institute2012
• Molecular Regulation Of HDL Metabolism &Reverse Cholesterol TransportNational Heart, Lung, And Blood Institute2010–2012
• HDL METABOLISM: Influence Of Extracellular LipasesNational Heart, Lung, And Blood Institute2009–2012
• Genetics Of Elevated High Density Lipoprotein CholesterolNational Heart, Lung, And Blood Institute2008–2012
• Effects Of Niacin On Lp(A), Oxidized LDL, And Inflammation In The Aim-High TrialNational Heart, Lung, And Blood Institute2008–2012
• Ips-Derived Hepatocytes For Interrogation Of Lipid PhenotypesNational Human Genome Research Institute2011
• Interrogation Of Novel Pathways Regulating VLDL Production And Plasma LipidsNational Heart, Lung, And Blood Institute2011
• Gene Therapy For DyslipidemiasNational Heart, Lung, And Blood Institute2010–2011
• Genetics Of Lipoprotein Metabolism And CVD In CKDNational Heart, Lung, And Blood Institute2009–2011
• Molecular Mechanisms And Pathways Of Novel Genomic Loci Regulating Plasma LipidsNational Heart, Lung, And Blood Institute2009–2010
• Identification Of Causal Variants At Novel GWAS Loci Associated With Lipid TraitsNational Heart, Lung, And Blood Institute2009–2010
• Comprehensive Biomarker Study To Capitalize On Existing GWAS In 10K South AsiansNational Heart, Lung, And Blood Institute2009–2010
• Markers Of The Metabolic Syndrome Linking Type 2 Diabetes And MI In South AsiaFogarty International Center2009–2010
• Molecular Regulation Of HDL Metabolism And Reverse Cholesterol TransportNational Heart, Lung, And Blood Institute2009
• HDL METABOLISM: Influence Of Extracellular LipasesNational Heart, Lung, And Blood Institute2009
• High Density Lipoprotein Metabolism Influence Of Extracellular PhospholipasesNational Heart, Lung, And Blood Institute2007–2008
• Gene Therapy For Dyslipidemia And AtherosclerosisNational Heart, Lung, And Blood Institute2004–2008
• APOE And Regulation Of COX-2 In VsmcsNational Heart, Lung, And Blood Institute2004–2008
• APO A-1 And Reverse Cholesterol Transport In VivoNational Heart, Lung, And Blood Institute2004–2007
• HDL Metabolism Influence Of Extracellular PhospholipasesNational Heart, Lung, And Blood Institute2004–2006
• Antioxidant And Anti-Inflammatory Mechanisms Of HDLNational Heart, Lung, And Blood Institute2003–2006
• Mentored Career Development In Patient Oriented ResearchNational Center For Research Resources2002–2006
• Orally Administered D-4F In Normal Healthy VolunteersNational Center For Research Resources2005
• Microsomal Triglyceride Transfer Protein (MTP) Inhibitor Bms-201038National Center For Research Resources2005
• Mechanism Of Pi-Related Dyslipidemia And Atherosclerosis In HIV SubjectsNational Center For Research Resources2005
• Htg Implitapide StudyNational Center For Research Resources2005
• Hofh Implitapide StudyNational Center For Research Resources2005
• Hefh Implitapide StudyNational Center For Research Resources2005
• Effects Of Rosiglitazone On HDL In Non-Diabetic Patients With Metabolic SyndromeNational Center For Research Resources2005
• Hdl-Cholesterol And Inflammation And Oxidative StressNational Center For Research Resources2004–2005
• A Mechanistic Study Of The Effects Of Rosiglitazone On HDL MetabolismNational Center For Research Resources2004–2005
• Association Of Coronary Calcification With Genetic Markers For AtherosclerosisNational Center For Research Resources1997–2005
• Abnormal Plasma Lipid Levels In Persons At Risk For Premature CHDNational Center For Research Resources1996–2005
• Gordon Research Conference: Lipoprotein Metabolism 2004National Heart, Lung, And Blood Institute2004
• Rosiglitazone On HDL In Non-Diabetic Patients With The Metabolic SyndromeNational Center For Research Resources2004
• Mechanism Of Pi-Related Dyslipidemia And AtherosclerosisNational Center For Research Resources2004
• Bms-201038 In Patients With Homozygous Familial HypercholesterolemiaNational Center For Research Resources2004
• Mechanism Of Pi-Related Dyslipidemia And AtherosclerosisNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
• APO A-1 And Reverse Cholesterol Transport In VivoNational Heart, Lung, And Blood Institute2003
• HDL Metabolism:Influence Of Extracellular PhospholipasesNational Heart, Lung, And Blood Institute2000–2003
• Antioxidant And Antiinflammatory Mechanisms Of HDLNational Heart, Lung, And Blood Institute2002
• Soft Gel Containing Plant Stanol Esters To Help Reduce Total And LDL CholesterolNational Center For Research Resources2000–2002
• Gene Therapy For Fh: Evaluation With Lipoprotein Kinetic StudiesNational Center For Research Resources2000–2002
• Ex Vivo Gene Therapy For Familial HypercholesterolemiaNational Center For Research Resources2000–2002
• Chronic Dosing Of Bms-201038 And Hepatic Fat Accumulation, And ReversibilityNational Center For Research Resources2000–2002
• Gene Therapy Of AtherosclerosisNational Heart, Lung, And Blood Institute1999–2002
• Cellular Basis Of Antiatherogenesis By Apolipoprotein ENational Heart, Lung, And Blood Institute1998–2001
• Yogurt Containing Plant Stanol Esters To Help Reduce Total LDL ChlstrNational Center For Research Resources1999–2000
• Effect Of Increasing Doses Of Micronized Fenofibrate On HypertriglycerimediaNational Center For Research Resources1999–2000
• Gene Therapy For Fh--Evaluation With Lipoprotein Kinetic StudiesNational Center For Research Resources1997–1999
• HDL Metabolism--Influence Of Spla2 And SAANational Heart, Lung, And Blood Institute1996–1998